Showing results (1751-1760 of 9,628) with videos related to
Sort By:
Pageof 963
Leukemia|March 12, 2009
Role of autologous and allogeneic stem cell transplantation in myelomaW I BensingerLeukemia|March 14, 2009
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1S Jeha, D Pei, S C Raimondi, et al.Leukemia|October 7, 2006
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cellsM Kraus, T Rückrich, M Reich, et al.Leukemia|October 7, 2006
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosisN C Gutiérrez, M V Castellanos, M L Martín, et al.Leukemia|October 7, 2006
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myelomaR Fonseca, S A Van Wier, W J Chng, et al.Leukemia|January 1, 1991
Non-Hodgkin's lymphomas of primary follicle/mantle zone originD D WeisenburgerLeukemia|December 16, 2006
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patientsN Gangat, A P Wolanskyj, R F McClure, et al.Leukemia|December 16, 2006
T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(-)CD7(+) common lymphoid progenitors expressing lymphoid-specific genesI Hoebeke, M De Smedt, F Stolz, et al.Leukemia|August 11, 2007
Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cellsT Sanda, T Okamoto, Y Uchida, et al.Leukemia|August 11, 2007
Overexpression of a hematopoietic transcriptional regulator EDAG induces myelopoiesis and suppresses lymphopoiesis in transgenic miceC-Y Li, Y-Q Zhan, W Li, et al.Pageof 963